News & Updates

In the treatment of patients with familial hypercholesterolemia, adding alirocumab to high-intensity statin therapy leads to a significant reduction in plaque burden and plaque stabilization, according to data from the ARCHITECT* study.

Maximal endoscopic ablation prior to treatment with reverse thermal polymer gel of mitomycin C (UGN-101) treatment appears to lead to fewer patients with upper tract urothelial carcinoma at first endoscopy and fewer adverse events (AEs) when compared with primary chemoablative therapy, suggests a recent study.

Older patients and women with chronic aortic regurgitation (AR) present with smaller left ventricular (LV) volumes than do younger patients and men, and they also develop adverse events (AEs) at lower LV volumes, reports a study.

Individuals engaging in more physical activities had lower risks of hospitalization for a multitude of common health conditions, according to a prospective cohort study using data from the UK Biobank.

Taking nutritional supplements before and throughout pregnancy puts children at lower risk of rapid weight gain and high body mass index, according to data from the NiPPeR trial.

The use of gemcitabine concurrently with cisplatin and intensity-modulated radiation therapy appears to improve response and prolong progression-free survival in women with locally advanced vulvar cancer not amenable to surgical resection, according to the results of the phase II NRG Oncology Trial 279 (NRG-GOG-0279) presented at SGO 2023.

In patients undergoing transrectal ultrasound-guided prostate biopsy, prophylaxis with either fosfomycin or cefixime leads to fewer infectious complications, as shown in a study presented at the 38th Annual EAU Congress (EAU 2023).